Drugs Made In America Acquisition Corp. Ordinary Shares

NASDAQ:DMAA

Shell Companies

Financial Services
$10.90 +0.00%

+$0.00 today

Market cap
$264.62M
Beta
0.00
P/E (TTM)
36.7
EPS (TTM)
$0.29
52W Low $10.17High $10.63

Volume 0.00M

Average 0.11M

DMAA Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Drugs Made In America Acquisition Corp. Ordinary SharesNASDAQ: DMAA

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) dips below year-ago levels

Q1 FY2026 weighted avg shares (diluted) of 23M shares fell 9.8% year over year, behind the +96.3% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 9.5% from the prior quarter.

What to watch

Whether quarterly growth recovers from -9.8% toward the trailing-twelve-month pace of +96.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
23M+9.5% QoQ
Last fiscal yearDec 2025
21.01M+145.1% YoY
LTMMar 2026
25.13M+96.3% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-9.8%——
1 year+145.1%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
21.01M USD
Year-over-year change
+145.1%
1-year CAGR
+145.1%

Weighted Avg Shares (Diluted) vs competitors

How DMAA compares with its peers on the latest reported figures

  • DMAA's LTM Mar 2026 weighted avg shares (diluted) of 25.13M shares is the 5th highest of the 10 companies compared; the peer median is 24.67M shares.
  • Its year-over-year change of +96.3% is the 2nd highest of 5, against a peer median of +11.1%.
DMAA Competitors Peer median
Weighted Avg Shares (Diluted) for DMAA and competitors
Company Period LTM YoY 3-year CAGR
LOKVLive Oak Acquisition Corp. V Class A Ordinary SharesLTM Mar 202630.66M ——
ALFCenturion Acquisition Corp.LTM Mar 202630.55M +13.3%—
MLACMountain Lake Acquisition Corp.LTM Mar 202627.4M +9.0%+8.5%
TACHTitan Acquisition Corp.LTM Mar 202626.75M +436615.5%—
DMAADrugs Made In America Acquisition Corp. Ordinary SharesLTM Mar 202625.13M +96.3%—
RTACRenatus Tactical Acquisition Corp I Class A Ordinary SharesLTM Mar 202624.67M ——
SIMASIM Acquisition Corp. ILTM Mar 202623M -23.4%—
OYSEOyster Enterprises II Acquisition CorpLTM Mar 202621.68M ——
TACOBerto Acquisition Corp.LTM Mar 202620.49M ——
TACOUBerto Acquisition Corp. UnitLTM Mar 202616.88M ——
Peer median (excluding DMAA) 24.67M+11.1%+8.5%

Competitors are the stored peer set for DMAA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD

Drugs Made In America Acquisition Corp. Ordinary Shares

NASDAQ:DMAA

Intrinsic Alpha fair value

Locked

Current Price

$10.90

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.